Qilian International Holding Group (Qilian International Holding Group) EBIT per Share : $-0.07 (TTM As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Qilian International Holding Group EBIT per Share?

Qilian International Holding Group's EBIT per Share for the six months ended in Sep. 2023 was $-0.08. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.07.

During the past 12 months, the average EBIT per Share Growth Rate of Qilian International Holding Group was -197.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Qilian International Holding Group's EBIT per Share or its related term are showing as below:

During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Qilian International Holding Group was 73.80% per year. The lowest was -29.50% per year. And the median was -20.20% per year.

QLI's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.95
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Qilian International Holding Group's EBIT for the six months ended in Sep. 2023 was $-2.73 Mil.

Qilian International Holding Group EBIT per Share Historical Data

The historical data trend for Qilian International Holding Group's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qilian International Holding Group EBIT per Share Chart

Qilian International Holding Group Annual Data

Trend

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

EBIT per Share

Get a 7-Day Free Trial

0.21

0.17

0.09

0.07

-0.07

Qilian International Holding Group Semi-Annual Data
	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EBIT per Share	Get a 7-Day Free Trial								0.01	0.04	0.03	0.01	-0.08

Qilian International Holding Group EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Qilian International Holding Group's EBIT per Share for the fiscal year that ended in Sep. 2023 is calculated as

	EBIT per Share		(A: Sep. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-2.418	/	35.750
=	-0.07

Qilian International Holding Group's EBIT per Share for the quarter that ended in Sep. 2023 is calculated as

	EBIT per Share		(Q: Sep. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-2.725	/	35.750
=	-0.08

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.07

Qilian International Holding Group (NAS:QLI) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Qilian International Holding Group EBIT per Share Related Terms

Thank you for viewing the detailed overview of Qilian International Holding Group's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Qilian International Holding Group (Qilian International Holding Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qilian International Holding Group Ltd (NAS:QLI) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jiuquan Economic and Technological Development Zone, Gansu Province, Jiuquan, CHN, 735000

Website

http://ir.qlsyy.net

Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.